StemCells, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
12 août 2014 16h02 HE
|
StemCells, Inc.
NEWARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2014 Financial Results
05 août 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Closing of $20 Million Offering
18 juil. 2014 13h39 HE
|
StemCells, Inc.
NEWARK, Calif., July 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), today announced that it has closed its previously announced offering of common stock and short term warrants. The...
StemCells, Inc. Announces Proposed $20 Million Offering
15 juil. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), today announced its intent to offer and sell 11,299,435 shares of common stock and short term warrants for the purchase...
StemCells, Inc. Appoints Dr. Alan Trounson to Board of Directors
07 juil. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr. Trounson most recently served as...
StemCells, Inc. President and CEO Martin McGlynn to Present on a Regenerative Medicine Panel at the 2014 BIO International Convention
23 juin 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will be a panelist at the 2014 BIO International Convention on...
StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry Age-Related Macular Degeneration Trial
20 juin 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., June 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) yesterday announced that based on positive interim results, it has closed enrollment in its Phase I/II clinical trial...
StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial
19 juin 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) reported positive interim results from its Phase I/II clinical trial of the Company's proprietary HuCNS-SC® human...
StemCells, Inc. Strengthens Senior Executive Team
17 juin 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., June 17, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today one promotion and three new appointments to the Company's executive team. Stephen Huhn, M.D., F.A.C.S.,...
StemCells, Inc. to Participate at the 4th LD Micro Invitational Conference
29 mai 2014 17h23 HE
|
StemCells, Inc.
NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 4th LD Micro Invitational Conference, on Wednesday, June 4, at 11:30...